Abstract
This study investigated the effect of ethanol microinjected into the rostral ventrolateral medulla on the cardiovascular responses to in6arostral ventroleteal medulla administration of the excitatory amino acids l-glutamate and N-methyl- d-aspartate (NMDA) and on baroreflex-mediated heart rate responses (baroreflex sensitivity) in conscious freely moving Sprague-Dawley rats. l-Glutamate (5 nmol) or NMDA (25, 50, and 100 pmol) microlrjected into the rostral ventrolateral medulla elicited pressor and bradycardic responses. The cardiovascular responses elicited by both l-glutamate and NMDA were significantly ( p < 0.05) attenuated by intrarostrel ventrolateral medulla ethanol (10 μg) or 2-amino-5 acid (2 nmoq, a selective NMDA receptor antagonist, but not by ACSF. Enhancement of the cardiovascular responses to l-glutamate by intrarostra ventrolateral medulla p-chloromercuriphenylsulfonic acid (0.1 nmol), a glutamate uptake inhibitor, was reversed by subsequent ethanol, but not ACSF, microinjection. None of the treatments influenced baseline blood pressure or heart rate. Ethanol or 2-amino-5-phosphonopentanoic acid microinjected into the rostral ventrolateral medulla significantly ( p < 0.05) attenuated baroreflex sensitivity tested by phenylephrine. In contrast, p-chloromercuriphenylsulfonic acid significantly ( p < 0.05) enhanced baroreflex sensitivity (−2.14 ± 0.09 vs. −3.08 ± 0.18); subsequent ethanol micoinjection reversed this enhancement (−290 ± 0.21 vs. −1.86 ± 0.24). Equal volume of ACSF had no effect on baroreftex sensitivity of pretreated rats (−3.22 ± 0.31 vs. −2.98 ± 0.34). These results suggest that ethanol exerts a marked inhibitory action on glutamatergic pathways within the rostral ventrolateral medulla that act to enhance baroreftex sensitivity. The similarities between the inhibitory actions of ethanol and the selective NMDA receptor Mocker 2-amino-5-phosphonopentanoic acid on the cardiovascular responses to NMDA and on baroreflex sensitivity suggest that ethanol attenuates baroreflex sensitivity, at least in part, by blocking the NMDA receptors in the rostral ventrolateral medulla. This evidence is presented, for the first time, in the absence of the confounding effects of anesthetics.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.